Group B streptococcus

@article{Schuchat1999GroupBS,
  title={Group B streptococcus},
  author={Anne Schuchat},
  journal={The Lancet},
  year={1999},
  volume={353},
  pages={51-56}
}
During the 1990s the focus of group B streptococcus (GBS) disease research has shifted to prevention. Increased use of intrapartum antimicrobial prophylaxis in North America and Australia has led to substantial declines in perinatal disease. Vaccine development (initiated two decades earlier) has yielded results--for example, polysaccharide-protein conjugate vaccines given to women of reproductive age proved to be highly immunogenic and well tolerated. Also economic evaluations have assessed… CONTINUE READING